The observation that even in the absence of NASH severely obese patients carrying the 148 M variant had decreased VAT adiponectin mRNA expression is also in line with these findings and suggests that the reduced serum adiponectin associated with this genetic polymorphism is determined by impaired transcription of the gene in the adipose tissue. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatohepatitis.